ID   A431-AC3
AC   CVCL_B5YD
DR   cancercelllines; CVCL_B5YD
DR   Wikidata; Q111732846
RX   PubMed=10764804;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; 3236; EGFR + HGNC; 9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Transfected with: HGNC; 4056; G6PC1.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
RX   PubMed=10764804; DOI=10.1074/jbc.M908096199;
RA   Caraco C., Aloj L., Chen L.-Y., Chou J.Y., Eckelman W.C.;
RT   "Cellular release of [18F]2-fluoro-2-deoxyglucose as a function of the
RT   glucose-6-phosphatase enzyme system.";
RL   J. Biol. Chem. 275:18489-18494(2000).
//